Published in Cardiovasc Drugs Ther on November 01, 2001
Apoptosis in cardiac disease: from basics to clinics--an editorial commentary. Cardiovasc Drugs Ther (2001) 0.75
The whiplash syndrome--common sense revisited. J Rheumatol (1997) 7.20
Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol (2000) 7.17
Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation (1995) 2.91
Pathogenesis of edema in constrictive pericarditis. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones before and after pericardiectomy. Circulation (1991) 2.28
Evaluation of phospholipid peroxidation as malondialdehyde during myocardial ischemia and reperfusion injury. Am J Physiol (1991) 2.28
Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-alpha. Eur Heart J (1999) 2.12
Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality. Eur Heart J (2002) 1.98
PHOX2B mutations and polyalanine expansions correlate with the severity of the respiratory phenotype and associated symptoms in both congenital and late onset Central Hypoventilation syndrome. J Med Genet (2004) 1.91
The heritability and genetics of frontotemporal lobar degeneration. Neurology (2009) 1.86
The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function. Am J Cardiol (2001) 1.68
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes. Heart (2000) 1.58
Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. Br Heart J (1993) 1.58
Efficacy of ivabradine in combination with Beta-blocker versus uptitration of Beta-blocker in patients with stable angina. Cardiovasc Drugs Ther (2011) 1.56
Sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure. Eur Heart J (1996) 1.56
Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly and in combination, for diagnosis of hibernating myocardium. Eur Heart J (2000) 1.54
Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium. Am J Cardiol (1980) 1.54
Occurrence of oxidative stress during reperfusion of the human heart. Circulation (1990) 1.53
Biopsychosocial solutions to TMD. J Can Dent Assoc (1999) 1.51
Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation (1989) 1.44
Importance of sympathetic activation for the expression of Na+-Ca2+ exchanger in end-stage failing human myocardium. Eur Heart J (2002) 1.43
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation (2001) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Long-term results of coronary artery bypass grafting procedure in the presence of left ventricular dysfunction and hibernating myocardium. Eur J Cardiothorac Surg (2001) 1.37
The strain of cervical sprains. Am J Nurs (2001) 1.36
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review. Ann N Y Acad Sci (2004) 1.32
The protective role of heat stress in the ischaemic and reperfused rabbit myocardium. J Mol Cell Cardiol (1992) 1.31
Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery. Circulation (1992) 1.30
Oxidative stress during myocardial ischaemia and heart failure. Curr Pharm Des (2004) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation (1997) 1.22
Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol (1994) 1.21
Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci Lett (2000) 1.21
Oxygen-mediated myocardial damage during ischaemia and reperfusion: role of the cellular defences against oxygen toxicity. J Mol Cell Cardiol (1985) 1.20
Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors. EMBO J (1999) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
A prospective cohort study of the outcome of acute whiplash injury in Greece. Clin Exp Rheumatol (2000) 1.18
Pre-formed articulating knee spacer in two-stage revision for the infected total knee arthroplasty. Int Orthop (2005) 1.18
Correlation of clinical findings, collision parameters, and psychological factors in the outcome of whiplash associated disorders. J Neurol Neurosurg Psychiatry (2004) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. Am J Cardiol (2001) 1.12
The emergence of the volume transmission concept. Brain Res Brain Res Rev (1998) 1.11
The effects of ruthenium red on mitochondrial function during post-ischaemic reperfusion. J Mol Cell Cardiol (1982) 1.11
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL. Int J Cardiol (2010) 1.11
Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis factor-alpha. Circulation (1999) 1.10
Neck injury and chronic pain syndromes: comment on the article by Buskila et al. Arthritis Rheum (1998) 1.08
Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition. Circulation (1998) 1.08
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Comment on Ng et al.: 'Laypersons' expectations of recovery and beliefs about whiplash injury: a cross-cultural comparison between Australians and Singaporeans'. Eur J Pain (2013) 1.06
Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial. Heart (2007) 1.05
Effort testing in patients with fibromyalgia and disability incentives. J Rheumatol (2001) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol (2003) 1.04
Oxygen free radicals and myocardial damage: protective role of thiol-containing agents. Am J Med (1991) 1.04
Oxidative stress during myocardial ischaemia and heart failure. Eur Heart J (1998) 1.04
Effect of alpha-tocopherol on hypoxic-perfused and reoxygenated rabbit heart muscle. J Mol Cell Cardiol (1978) 1.03
Enhanced expression and activity of xanthine oxidoreductase in the failing heart. J Mol Cell Cardiol (2000) 1.02
Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis (2014) 1.02
The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of N-acetyl cysteine. J Mol Cell Cardiol (1988) 1.01
Changes in the cardiac glutathione status after ischemia and reperfusion. Experientia (1985) 1.00
Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease. Mov Disord (1992) 1.00
Apoptosis of skeletal muscle myofibers and interstitial cells in experimental heart failure. J Mol Cell Cardiol (1998) 0.99
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model. Lab Invest (1991) 0.99
New insights on myocardial pyridine nucleotides and thiol redox state in ischemia and reperfusion damage. Cardiovasc Res (2000) 0.98
The biopsychosocial model--a tool for rheumatologists. Baillieres Best Pract Res Clin Rheumatol (2000) 0.98
Heat stress limits infarct size in the isolated perfused rabbit heart. Cardiovasc Res (1993) 0.98